What patient education, medication regimen, activity restrictions, and return precautions should be provided to a patient diagnosed with acute pericarditis?

Patient Education and Return Precautions for Pericarditis

Medication Regimen

Patients diagnosed with acute pericarditis should be started on combination therapy with high-dose NSAIDs (aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours) plus weight-adjusted colchicine (0.5 mg once daily if <70 kg, 0.5 mg twice daily if ≥70 kg) for a minimum of 3 months. 1, 2

First-Line Treatment Details

• NSAIDs should be continued for 1-2 weeks at full dose with gastroprotection (proton pump inhibitor) 2, 3
• Tapering should only begin after complete symptom resolution AND CRP normalization 1, 2
• Aspirin taper: decrease by 250-500 mg every 1-2 weeks 1, 2
• Ibuprofen taper: decrease by 200-400 mg every 1-2 weeks 1, 2
• Colchicine must be continued for the full 3 months without tapering 2, 3

Critical Medication Warnings

• Premature discontinuation or inadequate treatment duration is the most common cause of recurrence 2, 3
• Without colchicine, recurrence rates are 15-30% after first episode and up to 50% after first recurrence 1, 2
• Corticosteroids should NOT be used as first-line therapy as they increase recurrence risk (odds ratio 4.3) and promote chronicity 2, 3

Activity Restrictions

Patients must completely avoid all exercise and strenuous physical activity until symptoms resolve AND CRP, ECG, and echocardiogram normalize. 2, 3

Specific Activity Guidelines

• Non-athletes: restrict exercise until complete clinical and laboratory resolution 2, 3
• Athletes: minimum 3-month exercise restriction even after symptom resolution 2, 3
• Return to activity should be gradual and only after documented normalization of inflammatory markers 2

Follow-Up Schedule

Patients require assessment after 1 week to evaluate response to anti-inflammatory therapy. 1, 3

Monitoring Parameters

• Serial CRP measurements are required to guide treatment duration and confirm therapeutic response 2, 3
• Repeat ECG and echocardiography before clearing for return to normal activities 2, 3
• Continue monitoring until complete resolution of symptoms, normalization of CRP, and resolution of ECG/echo abnormalities 2, 3

Return Precautions - When to Seek Immediate Care

Patients should return immediately or call 911 for any of the following warning signs:

High-Risk Features Requiring Emergency Evaluation

• High fever >38°C (>100.4°F) 1, 4
• Worsening or severe chest pain despite medication 1, 4
• New shortness of breath, difficulty breathing, or rapid breathing 1, 3
• Lightheadedness, dizziness, or feeling faint 1, 3
• Rapid heart rate or palpitations 1, 3

Signs of Cardiac Tamponade (Life-Threatening)

• Severe shortness of breath that worsens when lying flat 3, 5
• Confusion or altered mental status 3
• Chest pressure or feeling of fullness 3
• Swelling in legs or abdomen 3

Signs of Treatment Failure

• No improvement in chest pain within 7 days of starting NSAIDs 1, 4
• Recurrence of chest pain after initial improvement 1, 4
• Development of new symptoms 1, 3

Patient Education on Expected Course

Most patients with idiopathic or viral pericarditis have a good prognosis with appropriate treatment, with 70-85% experiencing a benign course. 1, 5

What to Expect

• Chest pain typically improves within 1-2 weeks with proper treatment 2, 4
• Complete resolution of inflammation may take several weeks 2, 4
• Medication tapering occurs over weeks to months, guided by symptoms and CRP levels 1, 2
• Total treatment duration is typically 3 months minimum 2, 3

Recurrence Risk Education

• Recurrence occurs in 15-30% of patients not treated with colchicine 1, 5
• Colchicine reduces recurrence risk by approximately 50% 2, 5
• If recurrence occurs, colchicine duration extends to at least 6 months 1, 2

Medication Side Effects to Report

NSAID-Related

• Black or bloody stools (gastrointestinal bleeding) 2
• Severe stomach pain 2
• Worsening kidney function (decreased urination, swelling) 2

Colchicine-Related

• Severe diarrhea or abdominal cramping 1, 2
• Muscle weakness or pain 1, 2
• Nausea or vomiting that prevents medication adherence 1, 2

Common Pitfalls to Avoid

The most critical error is stopping medications too early or tapering before complete symptom resolution and CRP normalization. 2, 3

• Never stop colchicine before 3 months even if feeling better 2, 3
• Do not resume exercise or strenuous activity based on symptom improvement alone—require documented laboratory and imaging normalization 2, 3
• Do not accept corticosteroids as first-line therapy unless NSAIDs and colchicine are contraindicated 2, 3
• Ensure gastroprotection is prescribed with NSAIDs to prevent gastrointestinal complications 2, 3